Seizure associated with chloroquine therapy in a patient with systemic lupus erythematosus.
Tristano
Antonio G
AG
Falcón
Luz
L
Willson
María
M
de Oca
Ivette Montes
IM
D000293:Adolescent; D000927:Anticonvulsants / Q000008:administration & dosage; D018501:Antirheumatic Agents / Q000009:adverse effects*; D015984:Causality; D002738:Chloroquine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D009498:Neurotoxins / Q000009:adverse effects; D010672:Phenytoin / Q000008:administration & dosage; D011241:Prednisone / Q000627:therapeutic use; D012164:Retinal Diseases / Q000139:chemically induced; D012640:Seizures / Q000139:chemically induced* / Q000503:physiopathology; D016896:Treatment Outcome
D000927:Anticonvulsants; D018501:Antirheumatic Agents; D009498:Neurotoxins; D010672:Phenytoin; D002738:Chloroquine; D011241:Prednisone